Bloginfo
November 7, 2022

Patient Survival Story presented at the North American Cystic Fibrosis Conference (NACFC)   Start-up developed in tandem with Sheba Medical Center pulmonologists   Or Yehuda, Israel and Philadelphia, PA, November 7, 2022 — Synchrony Medical’s LibAirty, helped save the life of a 38-year-old patient who traveled from Israel to the U.S., where she waited for 6 […]...

October 31, 2022

Or Yehuda, Israel, October 31, 2022 — BeWeld Medical, developer of a disruptive technology designed to automate the manufacturing processes of implanted medical devices, has signed a strategic investment agreement with global medical technology leader Boston Scientific.   BeWeld CTO, Abeer Khalailah and CEO, Asaf Gordon   “BeWeld’s technology has potential to advance the automation […]...

September 8, 2022

Or Yehuda, Israel, 8/9/22 — MEDX Xelerator’s latest initiative is the founding of NovaPulse Ltd., a bio-convergence company, which is addressing the multi-billion-dollar peripheral artery disease (PAD) market and helping the millions of claudication patients who suffer from pain and have trouble walking because of the insufficient blood supply in their legs. NovaPulse was formed […]...

July 12, 2022

Study published in the Journal of Surgical Research     The findings are the basis of a multi-center clinical trial currently ongoing at Rabin Medical Center, Sheba Medical Center, Shamir Medical Center and Kaplan Medical Center   Or Yehuda, Israel, July 12, 2022 — A pre-clinical study using Exero Medical’s post-operative tissue healing monitoring technology, […]...

June 30, 2022

The MEDX Xelerator medtech incubator in Sakhnin is officially open for business. Area entrepreneurs – we want to hear from you! Here are highlights from the wonderful opening event this week (28/6/22), which included inspiring remarks, fabulous catering and a Medtech demo table.   https://youtu.be/7uiC8Kfx-yY  ...

This website uses cookies

We use cookies to enhance your experience on our site. Visit our Privacy Policy and Terms and Conditions of Use to learn more. By using our site, you agree to our use of cookies.

Agree | Learn More
Subscribe to Newsletter